Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)
Clinical trial NCT00475215 · COMPLETED
Trial details
- NCT number
- NCT00475215
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-27
- Primary completion
- 2006-08-21
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.